Results 51 to 60 of about 17,340 (213)

Development of a field diagnostic tool for Schistosoma mansoni Praziquantel resistant markers in selected endemic communities [PDF]

open access: yesResearch Ideas and Outcomes
Schistosomiasis is a neglected tropical disease that affects more than 200 million people and 45% of infections have been shown to occur in school-aged children. A large percentage of the disease burden lies in Africa. In 2012, the WHO outlined a roadmap
Maame Ekua Acquah   +3 more
doaj   +3 more sources

Infection with the Neorickettsial Organism Stellantchasmus falcatus Agent in an Arctic Fox (Vulpes lagopus)

open access: yesVeterinary Clinical Pathology, EarlyView.
ABSTRACT A 1‐year‐old female‐intact arctic fox (Vulpes lagopus) presented for diarrhea, lethargy, severe thrombocytopenia, and hyperbilirubinemia. Blood film evaluation revealed intracytoplasmic coccoid bacteria within moderate numbers of leukocytes consistent with infection by a rickettsial organism.
Jeremy P. Bessett   +3 more
wiley   +1 more source

Epidemiological interactions between urogenital and intestinal human schistosomiasis in the context of praziquantel treatment across three West African countries [PDF]

open access: yes, 2015
© 2015 Knowles et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are ...
Rollinson, D   +36 more
core   +1 more source

Effects of praziquantel on early life stages of Grass carp, Ctenopharyngodon idella

open access: yesVeterinární Medicína
This study aimed to assess the toxicity of the anthelmintic drug praziquantel in the early life stages of grass carp (Ctenopharyngodon idella). The toxicity was evaluated based on mortality, early ontogeny development, growth, oxidative stress biomarkers,
J Velisek   +5 more
doaj   +1 more source

The immune-dependence of chemotherapy in experimental schistosomiasis

open access: yesMemorias do Instituto Oswaldo Cruz, 1989
Experimental evidence indicates that immune effector mechanisms can enhance the activity of schistosomicidal drugs. Praziquantel, oxamniquine, hycanthone and antimony were less effective against Schistosoma mansoni infections in mice immunosuppressed by ...
M. J. Doenhoff
doaj   +1 more source

Tunable Polymeric Mixed Micellar Nanoassemblies of Lutrol F127/Gelucire 44/14 for Oral Delivery of Praziquantel: A Promising Nanovector against Hymenolepis nana in Experimentally-Infected Rats

open access: yesPharmaceutics, 2022
Hymenolepiasis represents a parasitic infection of common prevalence in pediatrics with intimidating impacts, particularly amongst immunocompromised patients.
Waleed M. Arafa   +8 more
doaj   +1 more source

Treatment with anthelminthics during pregnancy: what gains and what risks for the mother and child? [PDF]

open access: yes, 2011
In 1994 and 2002, respectively, the World Health Organisation proposed that treatment for hookworm and schistosomiasis could be provided during pregnancy.
Webb, Emily L   +18 more
core   +1 more source

Revisiting the Dissolution of Praziquantel in Biorelevant Media and the Impact of Digestion of Milk on Drug Dissolution

open access: yesPharmaceutics, 2022
Praziquantel is a poorly water-soluble drug used to treat parasitic infections. Previous studies have suggested that its rate and extent of dissolution in milk and biorelevant media are slow and limited compared to dissolution in the pharmacopoeial ...
Thomas Eason   +4 more
doaj   +1 more source

Praziquantel in clonorchiasis and opisthorchiasis [PDF]

open access: yes, 1981
A single stool examination revealed pathogenic intestinal parasites in 462 (58%) of 796 vietnamese and cambodian refugees. 56 (7.0%) were infected with Clonorchis sinensis and/or Opisthorchis viverrini. These patients received Praziquantel in a dosage of
Lang, W.   +4 more
core  

Safety of concurrent treatment of dogs with fluralaner (Bravecto™) and milbemycin oxime - praziquantel

open access: yesParasites & Vectors, 2014
Background Fluralaner (Bravecto™; Merck/MSD Animal Health) is a novel systemic ectoparasiticide for dogs providing long-acting flea and tick control after a single oral dose.
Feli M Walther   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy